Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9481703 HCV polymerase inhibitors

Patent 9481703 was granted and assigned to Medivir on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 1, 2016

Patent Application Number

14634449

Date Filed

February 27, 2015

Patent Citations Received

US Patent 12012431 Methods of preparing 1′-cyano nucleosides

0

US Patent 11939347 1′-cyano nucleoside analogs and uses thereof

0

US Patent 11975017 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

0

US Patent 11975012 Remdesivir treatment methods

0

US Patent 11660307 Methods for treating SARS CoV-2 infections

0

US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs

0

US Patent 11780844 Compounds and methods for treatment of viral infections

US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections

0

...

Patent Primary Examiner

Traviss C Mcintosh, III

Patent abstract

The invention provides compounds of the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9481703 HCV polymerase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool